CS212652B1 - C 2 substituted derivatives of barbiturates - Google Patents
C 2 substituted derivatives of barbiturates Download PDFInfo
- Publication number
- CS212652B1 CS212652B1 CS781879A CS781879A CS212652B1 CS 212652 B1 CS212652 B1 CS 212652B1 CS 781879 A CS781879 A CS 781879A CS 781879 A CS781879 A CS 781879A CS 212652 B1 CS212652 B1 CS 212652B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- barbiturates
- substituted derivatives
- solution
- denotes
- formula
- Prior art date
Links
- 229940125717 barbiturate Drugs 0.000 title description 9
- -1 amino, mercapto, imidazolyl Chemical group 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000243 solution Substances 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 4
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical class O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229960001412 pentobarbital Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 229960003279 thiopental Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000003946 cyclohexylamines Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 description 1
- ZFWAHZCOKGWUIT-UHFFFAOYSA-N 1-anilino-3-phenyliminourea Chemical compound C=1C=CC=CC=1N=NC(=O)NNC1=CC=CC=C1 ZFWAHZCOKGWUIT-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960004931 histamine dihydrochloride Drugs 0.000 description 1
- PPZMYIBUHIPZOS-UHFFFAOYSA-N histamine dihydrochloride Chemical compound Cl.Cl.NCCC1=CN=CN1 PPZMYIBUHIPZOS-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical group FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Description
Vynález se týká C? substituovaných derivátů bařbiturátů určených k přípravě specifických imunogenních látek proti barbiturétům a značených haptenů.The invention relates to C? substituted derivatives of barbiturates intended for the preparation of specific immunogenic agents against barbiturets and labeled haptenes.
Speeificita stanovení barbiturátů imunospecifickými metodami závisí hlavně na specifitě použitých protilátek. Všechny dosud popsané metody používaly k imunizaci polosyntetických antigenů, kde byla determinantní skupina barbiturátů připojena na nosič pomocí substituentu na Cj. Takto připojená determinantní skupiny stimulují tvorbu protilátek, které nerozlišují dobře barbituráty s různými C^ substituenty a nerozlišuji také barbituráty a jejich fyziologicky neúčinné metabolity vznikající substitucí na C^. Dosud známé deriváty barbiturátů nebylo možno připojit pomocí substituentu v poloze Cg na bílkovinný nosič, nebo jiný nosič používaný v imunologii k stimulaci tvorby protilátek proti nízkomolekulárním látkám. Takové navázání barbiturátů na nosič je nutné pro přípravu antigenů, který stimuluje tvorbu specifických protilátek proti C^ substituovaných barbiturétům. Dosud známé deriváty barbiturátů nedovolovaly přípravu haptenů značených v poloze Cg, které jsou potřebné pro přípravu isotopicky značených haptenů.The specificity of the determination of barbiturates by immunospecific methods mainly depends on the specificity of the antibodies used. All of the methods described so far have used to immunize semi-synthetic antigens where a determinant group of barbiturates has been attached to a support using a substituent on C 1. The determinant groups thus attached stimulate the production of antibodies which do not distinguish well the barbiturates with the various C 1-6 substituents and also do not distinguish the barbiturates and their physiologically inactive metabolites resulting from the C 2 substitution. The hitherto known barbiturate derivatives could not be attached via a substituent at the Cg position to a protein carrier or other carrier used in immunology to stimulate the production of antibodies against low molecular weight substances. Such binding of barbiturates to a carrier is necessary for the preparation of antigens that stimulate the production of specific antibodies against C 1 substituted barbiturets. The hitherto known barbiturate derivatives did not allow the preparation of Cg-labeled haptenes which are required for the preparation of isotopically-labeled haptenes.
Uvedené nedostatky odstraňuje vynález, jehož podstatou jsou Cg substituované deriváty barbiturátů k přípravě specifických imunogenních látek proti barbiturátům a značených haptenů. Tyto C£ substituované deriváty barbiturátů jsou tvořeny látkou obecného vzorce R1These drawbacks are overcome by the invention which is based on Cg substituted barbiturate derivatives for the preparation of specific immunogenic agents against barbiturates and labeled haptenes. These C 6 substituted barbiturate derivatives are represented by the formula R 1
zR3z R 3
C = N(CHg)nA R2Z C-N //C = N (CH 3) n A R 2 Z CN //
OO
R, kde η R1» r2 r3, r4 AR, where η R 1 r r 2 r 3, r 4 A
Vynález blíže je 1 až 6 značí alkyl s 1 až 6 atomy uhlíku nebo fenyl značí vodík nebo metyl značí skupinu schopnou reakce s postranními řetězci aminokyselin v bílkovinách, zahrnující karboxyl, hydroxyl, aminoskupinu, merkaptoskupinu, imidazolyl, p-hydroxyfenyl, a lze je chemicky připravit, například způsoby podle příkladů.More particularly, the invention is 1-6 denotes alkyl of 1-6 carbon atoms or phenyl denotes hydrogen or methyl denotes a group capable of reacting with the side chains of amino acids in proteins, including carboxyl, hydroxyl, amino, mercapto, imidazolyl, p-hydroxyphenyl, and can be chemically prepare, for example, the methods of the examples.
objasňují následující konkrétní příklady.the following specific examples illustrate.
Příklad 1Example 1
2-(karboxymethylimino)-5-ethyl-5-(1-methylbutyl)-dihydro-4,6-(1H,5H)-pyrimidindion vzorce I,2- (carboxymethylimino) -5-ethyl-5- (1-methylbutyl) -dihydro-4,6- (1H, 5H) -pyrimidinedione of formula I,
H O \ / \ ^2Η5 cHO \ / \ ^ 2 Η 5 c
\.(CHZJN=Č ho7 \-c 'ch.ch2.ch2-ch3 / \ i (I)(CH Z JN = Ch ho 7 \ -ch 'ch 2 .ch 2 -ch 3 / \ i (I)
CH·, byl připraven zahříváním· 2,4 g (10 mmol)5-ethyl-5-(1-niethylbutyl)-2-thiobarbiturové kyseliny 1 g glycerinu a 4 ml triethyleminu po dobu 16 hodin při teplotě 85 °C. Potom byl obsah baňky odpařen ve vakuu. Syrupovitý odparek byl rozpouštěn v 10 ml vody, jejíž reakce byla upravena hydrokarbonátem sodným na pH 7,6 a roztok byl vytřepán dvakrát 20 ml etheru. Hodnota pH byla upravena na 5,0 kyselinou solnou a roztok byl extrahován dvakrát 30 ml etheru. Etherové extrakty byly spojeny, vytřepény 2 ml vody, vysušeny bezvodým síranem sodným, profiltrovény s malým množstvím aktivního uhlí a odpařeny. Bezbarvý syrupovitý odparek, který byl vysušen nad Ρ2θ5· ztuhl v 1,2 g křehkého produktu.CH 2 was prepared by heating 2.4 g (10 mmol) of 5-ethyl-5- (1-methylbutyl) -2-thiobarbituric acid with 1 g of glycerin and 4 ml of triethylemine for 16 hours at 85 ° C. The contents of the flask were then evaporated in vacuo. The syrupy residue was dissolved in 10 ml of water, the reaction was adjusted to pH 7.6 with sodium bicarbonate and the solution was shaken twice with 20 ml of ether. The pH was adjusted to 5.0 with hydrochloric acid and the solution was extracted twice with 30 mL of ether. The ether extracts were combined, shaken with 2 ml of water, dried over anhydrous sodium sulfate, filtered with a small amount of activated carbon and evaporated. The colorless syrupy residue which was dried over θ2θ5 · solidified in 1.2 g of brittle product.
Tento produkt déval při tenkovrstvé chromatografii, nanesen v množství 50yug na silufol v rozpouštěcí soustavě butanol:amoniak 8:2 při ozářeni UV o vlnové délce 254 jedinou silnou obsahující skvrnu s 0,15.This product was applied in thin-layer chromatography in an amount of 50 µg onto silufol in a butanol: ammonia solvent system 8: 2 under UV irradiation at a wavelength of 254 the only strong spot containing 0.15.
Detekcí s ninhydrinem se neprokázal glycin, detekcí síranem rtutnatým a difenylkarbazonem nebyly prokázány barbituráty (pentobarbital, thiopental). Titrační křivka ukazuje na přítomnost jedné karboxylové skupiny v molekule. Zahříváním látky s 1 ml kyseliny solné v zatavené trubici při 120 °C po dobu dvou hodin se látka rozkládá na glycin a pentobarbital.Glycine was not detected by detection with ninhydrin, barbiturates (pentobarbital, thiopental) were not detected by detection with mercury sulphate and diphenylcarbazone. The titration curve indicates the presence of one carboxyl group in the molecule. Heating the substance with 1 ml of hydrochloric acid in a sealed tube at 120 ° C for two hours decomposes the substance into glycine and pentobarbital.
Létka vzorce I byla použita při přípravě imunogenu. Látka vzorce I byla navázána přes aktivní ester s hydroxysukcinimidem na hovězí albumin. Bylo použito 25násobné molové množství aktivního esteru vůči albuminu, Z diferenčního spektra albuminu a konjugátu vzorce I s albuminem byl zjištěn molový poměr navázaných skupin na albumin 5:1. Tento poměr se nezměnil přesréžením imunogenu ethanolem. Imunizace osmi králíků byla provedena injekcemi do tlapek v množství ,00 fig imunogenu na králíka s kompletním Freundovým adjuvans. Po 4 týdnech byla zvířata znovu imunizována 50 /ig imunogenu a za 14 dní byl proveden první odběr. Dalěí odběry byly prováděny u čtyř krélíků, kteří měli nejvyšší titry protilátek při prvním odběru, po 4 až 6 týdnech vždy 10 až 14 dní po aplikaci 10»ug imunogenu.Compounds of formula I were used in the preparation of the immunogen. The compound of formula I was bound to bovine albumin via the hydroxysuccinimide active ester. A 25-fold molar amount of active ester relative to albumin was used, a molar ratio of 5: 1 bound groups to albumin was determined from the differential spectrum of albumin and the albumin conjugate of formula I. This ratio was not altered by truncating the immunogen with ethanol. Eight rabbits were immunized by injecting paws in an amount of 00 µg of rabbit immunogen with complete Freund's adjuvant. After 4 weeks the animals were re-immunized with 50 µg of immunogen and after 14 days the first collection was performed. Subsequent harvesting was performed on the four larvae who had the highest antibody titers at the first harvest, 4 to 6 weeks each 10 to 14 days after the administration of 10 µg of immunogen.
Z methanolového roztoku byl krystalován jako sůl s cyklohexylaminem o t. t. 194 až 195 °C za rozkladu. Elementární analýza ukázala dobrou shodu s navrženou strukturou:It was crystallized from the methanol solution as a cyclohexylamine salt, m.p. 194-195 ° C with decomposition. Elemental analysis showed good agreement with the proposed structure:
C Η NC Η N
59,66 % 8,96 % 14,65 %59,66% 8,96% 14,65%
59,23 % 9,03 % 14,4 % teorie: nalezeno:59,23% 9,03% 14,4% theory: found:
Sůl s cyklohexylaminem v methanolu má-e(d » 250 nm) = 1,518.104, sůl s dicyklohexylaminem má f(d = 250 nm) - 1,523.104.The cyclohexylamine salt in methanol has (d »250 nm) = 1.518.10 4 , the dicyclohexylamine salt has f (d = 250 nm) - 1.523.10 4 .
Příklad 2Example 2
2-(2-imidazolylethylimino)-5-ethyl-5(1-methylbutyl)-dihydro-4,6-(1H,5H)-pyrimidindion vzorce II2- (2-Imidazolylethylimino) -5-ethyl-5- (1-methylbutyl) -dihydro-4,6- (1H, 5H) -pyrimidinedione of Formula II
H ch2.H ch 2 .
H ch2 w c H / \/2H5 c c \|_z CH. CH2. CH2. CH3 CH2 H W C H / \ / 2H5 cc \ | _z CH. CH 2 . CH 2 . CH3
H7 \ CH3 (II) byl připraven zahříváním roztoku jednoho mmolu (0,24 g) thiopentalu, 1 mmolu (0,18 g) histamindihydrochloridu a 0,6 ml triethylaminu v 5 ml ethylenglykolu, po dobu 24 hodin při teplotě 85 °C. Rozpouštědlo bylo odpařeno ve vakuu, odparek rozpuStěn ve 3 ml vody a při pH 3 byl roztok vytřepán dvakrát 10 ml etheru. Potom bylo pH roztoku upraveno na 7,6 hydrokarbonátem sodným a roztok byl extrahován dvakrát 10 ml ethylacetátu. Spojené ethylacetátové extrakty byly extrahovány 2 ml vody, vysušeny bezvodým síranem sodným. Suchý extrakt byl profiltrovén po přidání malého množství aktivního uhlí a filtrát odpařen. 7 H \ CH3 (II) was prepared by heating a solution of one mmol (0.24 g) thiopental, 1 mmol (0.18 g) of histamine dihydrochloride and 0.6 ml of triethylamine in 5 ml of ethylene glycol for 24 hours at 85 ° C . The solvent was evaporated in vacuo, the residue was dissolved in 3 ml of water and at pH 3 the solution was shaken twice with 10 ml of ether. The pH of the solution was then adjusted to 7.6 with sodium bicarbonate, and the solution was extracted twice with 10 mL of ethyl acetate. The combined ethyl acetate extracts were extracted with 2 mL of water, dried over anhydrous sodium sulfate. The dry extract was filtered after addition of a small amount of activated carbon and the filtrate was evaporated.
Po odpaření bylo získáno 85 mg bílé pevné látky. V soustavě butanol:amoniak 8:2 na Silufolu dávala látka jedinou diazopozitivní skvrnu, absorbující při 254 nm s Rp 3 0,45. Zahřátím s kyselinou solnou v množství 1 mol/1 kyseliny, v zatavené trubici na 120 °C po dobu dvou hodin se látka rozkládá na histamin a pentobarbital. Hmotové spektrometrie je v souhlase s předpokládanou strukturou (M+ 319).Evaporation gave 85 mg of a white solid. In the system of butanol: ammonia 8: 2 to giving the substance Silufol diazopozitivní single spot, absorbs at 254 nm with Rp 3 0.45. Heating with 1 mol / L hydrochloric acid in a sealed tube at 120 ° C for two hours decomposes to histamine and pentobarbital. Mass spectrometry is in accordance with the assumed structure (M + 319).
Příklad 3Example 3
2-(2-aminoethylimino)-5-ethyl-5-(methylbutyl)-dihydro-4,6-(1H,5H)-pyrimidindion2- (2-Aminoethylimino) -5-ethyl-5- (methylbutyl) -dihydro-4,6- (1H, 5H) -pyrimidinedione
Byl připraven zahříváním 2,4 g thiopentalu s 13 ml 1,2-diaminoethanu (200 mml) při 100 °G po dobu 4 h. Diaminoethan byl potom oddestilovén za sníženého tlaku. Sirupovitý zbytek byl třen s malým množstvím bezvodého ethanolu. Přitom se vyloučila bílé sraženina Nažloutlý alkoholický roztok byl oddělen od sraženiny, odbarven přídavkem aktivního uhlí, profiltrován a odpařen ve vakuu. Odparek sirupovité konsistence byl sušen ve vakuovém exsikátoru nad 1?2Ο5· Chrómatógrafie na tenké vrstvě ukazovala v soustavě aceton:chloroform: :amoniak 27:3:2 na Silufolu jedinou UV absorbující skvrnu při RF 0,2.It was prepared by heating 2.4 g of thiopental with 13 ml of 1,2-diaminoethane (200 mml) at 100 ° C for 4 h. The diaminoethane was then distilled off under reduced pressure. The syrupy residue was rubbed with a small amount of anhydrous ethanol. A white precipitate was formed. The yellowish alcoholic solution was separated from the precipitate, decolourised by the addition of activated carbon, filtered and evaporated in vacuo. The syrup-like consistency residue was dried in a vacuum desiccator above 1? 2 Ο 5 · Thin layer chromatography showed acetone: chloroform:: ammonia 27: 3: 2 on Silufol as the only UV absorbing spot at R F 0.2.
Amorfní slabě nažloutlá hmota se po vysušení nad PgO^ snadno drtila na přéšek, který se ale ve styku se vzdušnou vlhkostí měnil na lepivou hmotu. Ve vodném roztoku dávala látka s kyselinou pikrovou žlutou sraženinu. Ta rozpouštěna v alkoholu a přesrážena vodou měla po vysušení nad P2°5 tePl°tu tůní 105 °C a prvkové složení odpovídající dipikrátu připravené látky.The amorphous, slightly yellowish mass, after drying over PgO ^, was easily crushed to a sieve, which in contact with air humidity turned into a sticky mass. In aqueous solution, the picric acid substance gave a yellow precipitate. It dissolved in alcohol and precipitated with water, was dried over P 2 ° 5 ° te Pl herein pools 105 ° C and elemental composition corresponding dipikrátu prepared compounds.
C Η N teorie: 41,3 % 4,2 % 19,2 % nalezeno: 41,15 % 4,7 % 18,94 %C Η N theory: 41.3% 4.2% 19.2% found: 41.15% 4.7% 18.94%
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS781879A CS212652B1 (en) | 1979-11-15 | 1979-11-15 | C 2 substituted derivatives of barbiturates |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS781879A CS212652B1 (en) | 1979-11-15 | 1979-11-15 | C 2 substituted derivatives of barbiturates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS212652B1 true CS212652B1 (en) | 1982-03-26 |
Family
ID=5428008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS781879A CS212652B1 (en) | 1979-11-15 | 1979-11-15 | C 2 substituted derivatives of barbiturates |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS212652B1 (en) |
-
1979
- 1979-11-15 CS CS781879A patent/CS212652B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5514559A (en) | Immunologically active conjugates and method for their preparation | |
| CA1308711C (en) | Derivatives of monophosphoryl lipid a and process for preparation | |
| EP0124502A2 (en) | Conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates | |
| KR920008065A (en) | Peptide Compounds, Methods For Making Them, And Pharmaceutical Compositions Containing Them | |
| CS87192A3 (en) | Novel polyethylene glycol (peg)conjugates of proteins | |
| DE3211263A1 (en) | HUMAN INTERFERON RELATED PEPTIDES, ANTIGENS AND ANTIBODIES, AND METHOD FOR THE PRODUCTION THEREOF | |
| NO160103B (en) | IODTYRONIN NIMMUNOGEN CONJUGATE AND IODTYRON INGREDIENTS FOR PREPARING THE IODTYRONIN NIMMUNOGEN CONJUGATE. | |
| JPH01230591A (en) | Artificial antigen having t-antigenic determinant | |
| CS200513B2 (en) | Process for preparing omega-aminoacylamidic compounds | |
| JPH11513691A (en) | Low molecular weight cells, bone marrow and immunostimulants | |
| Pressman et al. | The Reactions of Antiserum Homologous to the p-Azosuccinanilate Ion Group1a | |
| CS212652B1 (en) | C 2 substituted derivatives of barbiturates | |
| US5399672A (en) | Process for preparing immunoconjugates | |
| FI62089B (en) | FREQUENCY REQUIREMENT FOR THE PERFORMANCE OF PERIPHERAL BLODOMLOPPET NETWORK 7- (N- (3-PHENOXY-2-HYDROXIPROPYL) -N-AMINO) -1,3-DIALKYL-XANTINDERIVAT | |
| SU792869A1 (en) | Process for producing conjugated antigenes barbituric acid-immunogenic carrier | |
| JPH0331226B2 (en) | ||
| FI61885B (en) | FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE 5-FLUOROPYRIMIDIN-4-ONDERIVAT | |
| DE2819898A1 (en) | NEW SUBSTITUTED PHENYLACIC ACID AMIDE COMPOUNDS AND METHOD FOR THEIR PRODUCTION | |
| KR910008107B1 (en) | Process for the proparing muramyldipeptide active ester derivatives | |
| FI87560C (en) | INDICATOR OVER THE FOLLOWING SAMT FOERFARANDE FOER FRAMSTAELLNING AV DEM | |
| SU1736337A3 (en) | Method for synthesis of [@@@-(tert-butylaminomethyl)-3,4-dichlorobenzyl]- thioacetamide or its salts | |
| US4087609A (en) | Azido-triazines | |
| SU862822A3 (en) | Method of preparing n-cyano-n'-methyl-n"-/2-((4-methyl-5-imidazolyl)-methylthio)-ethyl/-guanidine | |
| JP7315063B2 (en) | Methods for producing stereoisomers | |
| UA128730C2 (en) | Alternative processes for the preparation of tubulysins and intermediates thereof |